Endothelin receptor antagonists: novel agents for the treatment of hypertension? (Q34119541)

31 July 2017

title

Endothelin receptor antagonists: novel agents for the treatment of hypertension? (English)

1 reference

31 July 2017

Moreau P

1

1 reference

31 July 2017

Dao HH

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

11

1 reference

31 July 2017

page(s)

1807-1821

1 reference

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Phosphodiesterase III and V inhibitors on pulmonary artery from pulmonary hypertensive rats: differences between early and established pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Extracellular matrix contraction by fibroblasts: peptide promoters and second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Increased plasma levels of endothelin in diabetic patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Small artery structure in hypertension. Dual processes of remodeling and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin in renal pathophysiology: from experimental to therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Regional distribution of endothelin receptor in porcine cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Bosentan in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Role of endothelin in the increased vascular tone of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin, vascular hypertrophy, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Early captopril treatment reduces plasma endothelin concentrations in the acute and subacute phases of myocardial infarction: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

21 January 2018

Endothelin antagonists

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

A novel orally active endothelin-A receptor antagonist, ZD1611, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1807

10.1517/13543784.8.11.1807

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference